Sartorius Stedim Biotech S.A. (LON:0RG8)

Market Cap	16.43B
Revenue (ttm)	2.39B
Net Income (ttm)	170.91M
Shares Out	n/a
EPS (ttm)	1.77
PE Ratio	96.14
Forward PE	42.64
Dividend	0.58 (0.29%)
Ex-Dividend Date	Apr 2, 2025

Volume	28,141
Average Volume	10,052
Open	204.00
Previous Close	204.40
Day's Range	197.80 - 204.00
52-Week Range	139.45 - 239.30
Beta	0.93
RSI	51.17
Earnings Date	Jul 22, 2025

About Sartorius Stedim Biotech

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transportation of intermediate and finished biological products. It also provides fluid management services; biolayer interferometry instruments; microbiolog...

• Industry: Laboratory Analytical Instruments
• Founded: 1978
• Employees: 9,901
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RG8

Financial Performance

In 2024, Sartorius Stedim Biotech's revenue was 2.78 billion, an increase of 0.16% compared to the previous year's 2.78 billion. Earnings were 175.10 million, a decrease of -43.57%.

Financial numbers in EUR